Bristol-Myers Squibb to Take Part in Citi 2018 Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Citi 2018 Global Healthcare Conference on Thursday, December 6, 2018 in New York. Tom Lynch, chief scientific officer, will answer questions about the company at 2:10 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181129005019/en/

Media: Carrie Fernandez, 609-252-5222, [email protected]

Investors: Tim Power, 609-252-7509, [email protected] or Bill Szablewski,
609-252-5894, [email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• Bristol-Myers Squibb Co. (BMY) PT Raised to $65 at HSBC
• Agog-Supported Works Win Two of Three Immersive Prizes at the 83rd Venice International Film Festival
• BMS myeloma CAR T therapy meets primary endpoint in phase 2 trial